VeriMomVeriMom
HIGH RISK

임신 중 imidazole을 피해야 할까요? | VeriMom

Imidazole (CAS 288-32-4) is listed by ECHA with a harmonised classification for developmental toxicity (Category 1B, H360D), which by your scoring rules is H360-level evidence -> h=3. The mechanistic basis for the classification is not well‐characterised in publicly available dossiers, so mechanism is scored as theoretical/uncertain (m=1). Dermal/topical cosmetic exposure would likely give low but measurable systemic exposure for an adult (e=1) unless formulation/route increases uptake; this is supported by ECHA/EU classification and multiple safety data sheets listing H360D.

ECHA regulatory hazard statements

  • H360D

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

imidazole은 임신 중 안전한가요?
Imidazole (CAS 288-32-4) is listed by ECHA with a harmonised classification for developmental toxicity (Category 1B, H360D), which by your scoring rules is H360-level evidence -> h=3. The mechanistic basis for the classification is not well‐characterised in publicly available dossiers, so mechanism is scored as theoretical/uncertain (m=1). Dermal/topical cosmetic exposure would likely give low but measurable systemic exposure for an adult (e=1) unless formulation/route increases uptake; this is supported by ECHA/EU classification and multiple safety data sheets listing H360D.
imidazole은 모유 수유 중 안전한가요?
Because imidazole has a harmonised developmental/teratogenic classification (H360D, Category 1B) the hazard for lactation/breastfeeding is elevated and scored h=3 per your rule for H360-level evidence. No specific human milk transfer or breastfeeding studies were identified in the sources consulted, so mechanistic evidence is limited (m=1). Maternal topical use would most likely give low but measurable systemic exposure (e=1) in adults; therefore potential transfer in milk cannot be excluded.
imidazole은 아기 피부에 안전한가요?
Hazard remains H360-level (h=3) because of ECHA harmonised developmental classification. Mechanistic data are limited (m=1). For baby skin (0–3 yr) exposure scoring increases by +1 compared with adults when the adult exposure is measurable: adult e=1 -> infant e=2 because infant skin has higher surface-area-to-weight and an immature barrier, increasing potential absorption.
VeriMom은 imidazole을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 imidazole을 27/100 (높은 위험)로 평가합니다.
임신 중 imidazole 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요